NEW YORK – Quest Diagnostics said Tuesday that it is acquiring select assets of Columbus, Ohio-based health system OhioHealth's outreach laboratory services business.
Under the deal, most outreach testing done by OhioHealth will move to Quest's Pittsburgh laboratory, while OhioHealth will continue to own and operate its hospital labs covering inpatient and hospital-based outpatient care as well as anatomic pathology and oncology.
The deal is expected to close in Q3 2024. Financial and other terms were not disclosed.
"As healthcare transforms, we need to ensure we can continue to provide high-quality care to our patients that also provides them value," Chris Clinton, president of OhioHealth Regional Market, said in a statement. "As a trusted industry leader, Quest has the specialization and scale to ensure our patients have continued access to high quality lab services that, in many cases, will be more affordable for patients."
"Our transaction with OhioHealth exemplifies our ability to attract and collaborate with high quality health systems seeking to optimize their lab services," Quest Chairman, President, and CEO Jim Davis said in a statement. "Health systems are increasingly turning to Quest because of our unique ability to deliver laboratory testing that is innovative, accessible, and cost-effective. This transaction also delivers on our strategy, which includes generating growth through accretive outreach lab acquisitions, and will extend our presence across Ohio."
The deal follows Quest's announcement last week that it was acquiring Canadian laboratory firm LifeLabs for C$1.35 billion.